Drug Induced Liver Injury due to Hydralazine: A Case Report and Review of Literature

Evan Botti MD¹, Michelle Likhtshteyn MD^1, , Ghulam Ilyas MD², Evan Marzouk¹ and Kakin R. Iong MD¹

¹Internal Medicine, SUNY Downstate Medical Center, Brooklyn, United States

²Department of Pathology, SUNY Downstate Medical Center, Brooklyn, United States

Cite this paper:
Evan Botti MD, Michelle Likhtshteyn MD, Ghulam Ilyas MD, Evan Marzouk and Kakin R. Iong MD. Drug Induced Liver Injury due to Hydralazine: A Case Report and Review of Literature. American Journal of Medical Case Reports. 2020; 8(5):115-118. doi: 10.12691/ajmcr-8-5-2

Abstract

Drug Induced Liver Injury (DILI)accounts for around 11% of all Acute Liver Failure (ALF)cases and are usually associated with over the counter supplements [1]. Hepatotoxicity due to Hydralazine is not commonly reported [2]. Often times DILI may have variable presentations and latency times, making diagnosis difficult. Here we present a 70-year-oldfemale with multiple medical problems who presented to the hospital with jaundice and abdominal pain and concluded to have hydralazine induced liver injury.

Keywords:
DILI hydralazine liver failure transaminitis liver injury

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Olson, K.R., Davarpanah, A.H., Schaefer, E.A., Elias, N., & Misdraji, J. (2017). Case 2-2017. An 18-Year-Old Woman with Acute Liver Failure. The New England journal of medicine, 376 3, 268-278 .
[2]	Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010; 52(6): 2065-2076.
[3]	Herman LL, Tivakaran VS. Hydralazine. [Updated 2019 Oct 7]. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470296/https://livertox.nih.gov/Hydralazine.htm
[4]	Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947.
[5]	Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002; 22: 145-155
[6]	Xu JJ, Diaz D, O'Brien PJ. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact 2004; 150: 115.
[7]	Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10: 1018-1023 View Article
[8]	Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology 2011; 53: 1377-1387
[9]	Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2014; 109: 950-966
[10]	Sharma M, Foge M, Mascarenhas D. A Suspected Case of Hydralazine-Induced Hepatotoxicity: A Case Report and Review of Literature. Am J Case Rep. 2018;19:800-803. Published 2018 Jul 7.
[11]	Hassan A, Hammad R, Cucco R, Niranjan S. Hydralazine-induced cholestatic hepatitis. Am J Ther. 2009; 16: 371-73
[12]	Kleiner DE. Recent Advances in the Histopathology of Drug-Induced Liver Injury. Surg Pathol Clin. 2018; 11(2): 297-311.
[13]	Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007; 25: 1135.
[14]	Bjornsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology. 2016; 63(2): 590-603
[15]	Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364.
[16]	Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000; 4: 73.